| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.856 | 38.270 | 86.339 | 104.801 | 124.876 | 110.897 | 155.506 | 159.565 | 278.812 | 207.809 |
| Total Income - EUR | 10.856 | 38.270 | 86.339 | 104.801 | 124.877 | 110.897 | 155.506 | 159.583 | 278.812 | 207.809 |
| Total Expenses - EUR | 12.889 | 21.129 | 28.761 | 32.473 | 54.766 | 62.456 | 75.282 | 100.231 | 108.367 | 83.051 |
| Gross Profit/Loss - EUR | -2.034 | 17.141 | 57.577 | 72.329 | 70.111 | 48.440 | 80.224 | 59.352 | 170.445 | 124.758 |
| Net Profit/Loss - EUR | -2.365 | 16.390 | 56.700 | 71.281 | 68.873 | 47.343 | 78.720 | 57.756 | 167.656 | 118.524 |
| Employees | 0 | 1 | 1 | 1 | 2 | 5 | 9 | 7 | 8 | 7 |
Check the financial reports for the company - Dr Zamfir & Ourfali Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 742 | 1.081 | 567 | 69 | 0 | 0 | 4.539 | 4.330 | 1.814 | 1.453 |
| Current Assets | 49 | 13.874 | 83.957 | 79.672 | 75.117 | 53.005 | 106.282 | 58.699 | 174.650 | 113.917 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 82.852 | 75.206 | 47.359 | 882 | 56.612 | 39.318 | 167.932 | 105.479 |
| Cash | 49 | 13.874 | 1.105 | 4.466 | 27.758 | 52.123 | 49.670 | 19.381 | 6.718 | 8.438 |
| Shareholders Funds | -2.073 | 14.338 | 57.155 | 71.719 | 69.302 | 47.839 | 79.329 | 58.243 | 168.142 | 119.007 |
| Social Capital | 45 | 45 | 438 | 430 | 421 | 413 | 404 | 406 | 404 | 402 |
| Debts | 2.864 | 617 | 27.368 | 8.022 | 5.814 | 5.165 | 31.492 | 4.785 | 8.322 | 4.800 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dr Zamfir & Ourfali Srl